)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Trinity Biotech
Trinity Biotech (TRIB) investor relations material
Trinity Biotech Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary21 Aug, 2026
Offering details and pricing
Registered 705,659,320 Class A ordinary shares, previously represented by 35,282,966 ADSs, each ADS initially representing 20 ordinary shares.
On July 24, 2026, the ADS ratio changed to one ADS representing 600 ordinary shares, equivalent to a one-for-thirty reverse ADS split.
After the ratio change, 1,176,099 ADSs represented the same number of underlying ordinary shares.
A Standby Equity Purchase Agreement allowed for the sale of ADSs up to $25 million in gross proceeds.
The offering was terminated on July 7, 2026, with 675,048,580 ordinary shares (1,125,081 ADSs) removed from registration.
Use of proceeds and capital allocation
The Standby Equity Purchase Agreement provided an option to raise up to $25 million in gross proceeds through ADS sales.
Management team and governance
John Gillard, Chief Executive Officer, signed the filing on behalf of the company.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Trinity Biotech
- Revenue up 43%, net loss halved, and major HIV test orders boost 2026 outlook.TRIB
Q1 2026 - Flexible $25M equity facility offers capital but poses major dilution risk for shareholders.TRIBRegistration filing
- Up to 33.8M ADSs may be sold for $25M, supporting operations but increasing dilution risk.TRIBRegistration filing
- Debt conversion enables up to 167.95M new ADSs, causing dilution but reducing liabilities.TRIBRegistration filing
- Revenue fell and net loss widened, but gross margin and adjusted EBITDA improved.TRIBQ4 2025
- Up to $25M in equity financing via ADS offering supports diagnostics growth amid high leverage and Nasdaq risks.TRIBRegistration filing
- Revenue and margins declined in Q1 2025, but a strong rebound is expected in Q2.TRIBQ1 2025
- Q3 revenue up 3%, Point-of-Care up 60%, and profitability initiatives progressing.TRIBQ3 2024
- Q2 revenue up 14%, Point-of-Care sales surged 119%, and CGM development advanced toward pivotal trials.TRIBQ2 2024
Next Trinity Biotech earnings date
Q2 202613 Nov, 2026
Trinity Biotech
Next Trinity Biotech earnings date
Q2 202613 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Trinity Biotech plc. focuses on the development, manufacturing, and marketing of diagnostic products for the clinical laboratory and point-of-care segments. The company's product portfolio includes diagnostic tests for infectious diseases, diabetes, hemoglobin disorders, and autoimmune conditions. Trinity Biotech serves healthcare providers, laboratories, and patients worldwide, offering reliable and high-quality diagnostic solutions. The company is headquartered in Bray, Ireland, and its shares are listed on the NASDAQ.